Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

5.3K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.

Journal of medicinal chemistry·2010
Same author

Evaluation of the association between the AC3 genetic polymorphisms and obesity in a Chinese Han population.

PloS one·2010
Same author

Structure of yeast regulatory subunit: a glimpse into the evolution of PKA signaling.

Structure (London, England : 1993)·2010
Same author

[Effect of Rhizoma Coptidis coadministration with Cortex Cinnamomi on tissue distribution of berberine in rats].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2010
Same author

Exosomal-like vesicles with immune-modulatory features are present in human plasma and can induce CD4+ T-cell apoptosis in vitro.

Transfusion·2010
Same author

Qualitative analysis and simultaneous quantification of phenolic compounds in the aerial parts of Salvia miltiorrhiza by HPLC-DAD and ESI/MS(n).

Phytochemical analysis : PCA·2010

Related Experiment Video

Updated: Sep 27, 2025

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

18.5K

Influenza Virus Entry inhibitors.

Jie Yang1, Shuwen Liu2

  • 1Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.

Advances in Experimental Medicine and Biology
|April 12, 2022
PubMed
Summary

Developing novel anti-influenza drugs targeting virus entry is crucial due to increasing drug resistance. This review examines influenza entry inhibitors and their clinical trial performance, offering insights into future antiviral strategies.

Keywords:
Entry inhibitorsHemagglutininInfluenza virusTherapeuticsVirus entry

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.4K
Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry
07:25

Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry

Published on: November 4, 2015

10.3K

Related Experiment Videos

Last Updated: Sep 27, 2025

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

18.5K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.4K
Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry
07:25

Measuring Attachment and Internalization of Influenza A Virus in A549 Cells by Flow Cytometry

Published on: November 4, 2015

10.3K

Area of Science:

  • Virology
  • Drug Discovery
  • Infectious Diseases

Background:

  • Influenza poses significant global health and economic challenges.
  • Emerging drug resistance necessitates novel antiviral therapies.
  • Virus entry is a critical step in the influenza life cycle, making it a key target for antiviral intervention.

Purpose of the Study:

  • To review the development of influenza entry inhibitors.
  • To analyze the clinical trial performance of various entry inhibitors.
  • To discuss open questions and assay methods for influenza virus entry inhibitors.

Main Methods:

  • Literature review of published studies on influenza entry inhibitors.
  • Analysis of clinical trial data for small molecule, natural product, and peptide-based inhibitors.
  • Overview of assay methodologies for evaluating influenza virus entry inhibition.

Main Results:

  • Various classes of influenza entry inhibitors have been developed, including small molecules, natural products, and peptides.
  • Clinical trial data for these inhibitors show varying degrees of efficacy and safety.
  • Established and emerging assay methods are available for assessing inhibitor performance.

Conclusions:

  • Targeting virus entry is a promising strategy for combating influenza infections, especially resistant strains.
  • Further research and development are needed to optimize existing entry inhibitors and discover new ones.
  • Standardized assay methods are essential for consistent evaluation of anti-influenza entry inhibitors.